Abstract
Graft failure in the transplantation of hematopoietic stem cells occurs despite donor-host genetic identity of human leukocyte antigens, suggesting that additional factors modulate engraftment. With the nobese diabetic (NOD)–severe combined immunodeficiency (SCID) xenotransplantation model, we found that the NOD background allowed better hematopoietic engraftment than did other strains with equivalent immunodeficiency-related mutations. We used positional genetics to characterize the molecular basis for this strain specificity and found that the NOD Sirpa allele conferred support for human hematopoiesis. NOD SIRP-α showed enhanced binding to the human CD47 ligand, and its expression on mouse macrophages was required for support of human hematopoiesis. Thus, we have identified Sirpa polymorphism as a potent genetic determinant of the engraftment of human hematopoietic stem cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Thomas, E.D. et al. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 49, 511–533 (1977).
Storb, R., Prentice, R.L. & Thomas, E.D. Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. N. Engl. J. Med. 296, 61–66 (1977).
Gale, R.P. et al. Prevention of graft rejection following bone marrow transplantation. Blood 57, 9–12 (1981).
Suda, T., Arai, F. & Hirao, A. Hematopoietic stem cells and their niche. Trends Immunol. 26, 426–433 (2005).
Lapidot, T., Dar, A. & Kollet, O. How do stem cells find their way home? Blood 106, 1901–1910 (2005).
Murphy, W.J., Kumar, V. & Bennett, M. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J. Exp. Med. 165, 1212–1217 (1987).
McKenzie, J.L., Gan, O.I., Doedens, M. & Dick, J.E. Human short-term repopulating stem cells are efficiently detected following intrafemoral transplantation into NOD/SCID recipients depleted of CD122+ cells. Blood 106, 1259–1261 (2005).
Wang, J.C.Y. et al. In Hematopoiesis—A Developmental Approach (ed. Zon, L.I.) 99–118 (Oxford University Press, New York, 2001).
Dorshkind, K., Pollack, S.B., Bosma, M.J. & Phillips, R.A. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid). J. Immunol. 134, 3798–3801 (1985).
Shultz, L.D. et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol. 154, 180–191 (1995).
Glimm, H. et al. Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-β2 microglobulin-null mice. J. Clin. Invest. 107, 199–206 (2001).
Greiner, D.L. et al. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. Am. J. Pathol. 146, 888–902 (1995).
Larochelle, A. et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat. Med. 2, 1329–1337 (1996).
O'Brien, B.A., Huang, Y., Geng, X., Dutz, J.P. & Finegood, D.T. Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced. Diabetes 51, 2481–2488 (2002).
Ogasawara, K. et al. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 18, 41–51 (2003).
Piganelli, J.D., Martin, T. & Haskins, K. Splenic macrophages from the NOD mouse are defective in the ability to present antigen. Diabetes 47, 1212–1218 (1998).
Anderson, M.S. & Bluestone, J.A. The NOD mouse: a model of immune dysregulation. Annu. Rev. Immunol. 23, 447–485 (2005).
Acha-Orbea, H. & McDevitt, H.O. The first external domain of the nonobese diabetic mouse class II I-A β chain is unique. Proc. Natl. Acad. Sci. USA 84, 2435–2439 (1987).
Kissler, S. et al. In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes. Nat. Genet. 38, 479–483 (2006).
Vijayakrishnan, L. et al. An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells. Immunity 20, 563–575 (2004).
Yamanouchi, J. et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat. Genet. 39, 329–337 (2007).
Shinkai, Y. et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68, 855–867 (1992).
Zijlstra, M. β2-microglobulin deficient mice lack CD4−8+ cytolytic T cells. Nature 344, 742–746 (1990).
Kagi, D. et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369, 31–37 (1994).
Shultz, L.D. et al. NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J. Immunol. 164, 2496–2507 (2000).
Prochazka, M., Serreze, D.V., Frankel, W.N. & Leiter, E.H. NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice. Diabetes 41, 98–106 (1992).
Serreze, D.V., Prochazka, M., Reifsnyder, P.C., Bridgett, M.M. & Leiter, E.H. Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene. J. Exp. Med. 180, 1553–1558 (1994).
Barclay, A.N. & Brown, M.H. The SIRP family of receptors and immune regulation. Nat. Rev. Immunol. 6, 457–464 (2006).
Sano, S., Ohnishi, H. & Kubota, M. Gene structure of mouse BIT/SHPS-1. Biochem. J. 344, 667–675 (1999).
van den Nieuwenhof, I.M., Renardel de Lavalette, C., Diaz, N., van Die, I. & van den Berg, T.K. Differential galactosylation of neuronal and haematopoietic signal regulatory protein-α determines its cellular binding-specificity. J. Cell Sci. 114, 1321–1329 (2001).
Seiffert, M. et al. Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47. Blood 94, 3633–3643 (1999).
Seiffert, M. et al. Signal-regulatory protein α (SIRPα) but not SIRPβ is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34+CD38− hematopoietic cells. Blood 97, 2741–2749 (2001).
Vernon-Wilson, E.F. et al. CD47 is a ligand for rat macrophage membrane signal regulatory protein SIRP (OX41) and human SIRPα1. Eur. J. Immunol. 30, 2130–2137 (2000).
Hatherley, D., Harlos, K., Dunlop, D.C., Stuart, D.I. & Barclay, A.N. The structure of the macrophage signal regulatory protein α (SIRPα) inhibitory receptor reveals a binding face reminiscent of that used by T cell receptors. J. Biol. Chem. 282, 14567–14575 (2007).
Veillette, A., Thibaudeau, E. & Latour, S. High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages. J. Biol. Chem. 273, 22719–22728 (1998).
Oldenborg, P.A., Gresham, H.D. & Lindberg, F.P. CD47-signal regulatory protein α (SIRPα) regulates Fcγ and complement receptor-mediated phagocytosis. J. Exp. Med. 193, 855–862 (2001).
Blazar, B.R. et al. CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells. J. Exp. Med. 194, 541–549 (2001).
Smith, R.E. et al. A novel MyD-1 (SIRP-1α) signaling pathway that inhibits LPS-induced TNFα production by monocytes. Blood 102, 2532–2540 (2003).
Alblas, J. et al. Signal regulatory protein α ligation induces macrophage nitric oxide production through JAK/STAT- and phosphatidylinositol 3-kinase/Rac1/NAPDH oxidase/H2O2-dependent pathways. Mol. Cell. Biol. 25, 7181–7192 (2005).
Shultz, L.D. et al. Regulation of human short-term repopulating cell (STRC) engraftment in NOD/SCID mice by host CD122+ cells. Exp. Hematol. 31, 551–558 (2003).
Hauser, S.P., Waldron, J.A., Upuda, K.B. & Lipschitz, D.A. Morphological characterization of stromal cell types in hematopoietically active long-term murine bone marrow cultures. J. Histochem. Cytochem. 43, 371–379 (1995).
Issaad, C., Croisille, L., Katz, A., Vainchenker, W. & Coulombel, L. A murine stromal cell line allows the proliferation of very primitive human CD34++/CD38− progenitor cells in long-term cultures and semisolid assays. Blood 81, 2916–2924 (1993).
Subramanian, S., Parthasarathy, R., Sen, S., Boder, E.T. & Discher, D.E. Species- and cell type-specific interactions between CD47 and human SIRPα. Blood 107, 2548–2556 (2006).
Latour, S. et al. Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-α: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation. J. Immunol. 167, 2547–2554 (2001).
Brown, E.J. & Frazier, W.A. Integrin-associated protein (CD47) and its ligands. Trends Cell Biol. 11, 130–135 (2001).
Oldenborg, P.A. et al. Role of CD47 as a marker of self on red blood cells. Science 288, 2051–2054 (2000).
Gardai, S.J. et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123, 321–334 (2005).
Ide, K. et al. Role for CD47-SIRPα signaling in xenograft rejection by macrophages. Proc. Natl. Acad. Sci. USA 104, 5062–5066 (2007).
Pozzilli, P., Signore, A., Williams, A.J. & Beales, P.E. NOD mouse colonies around the world—recent facts and figures. Immunol. Today 14, 193–196 (1993).
Gan, O.I. et al. Characterization and retroviral transduction of an early human lymphomyeloid precursor assayed in nonswitched long-term culture on murine stroma. Exp. Hematol. 27, 1097–1106 (1999).
Guenechea, G. et al. Transduction of human CD34+ CD38− bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors. Mol. Ther. 1, 566–573 (2000).
Acknowledgements
We thank Y. Slessarev for cord blood processing; A. Wong for assistance with flow cytometry; O. Gulban for assistance with human HapMap data and sequence analysis; E. Brown and T. Chen (University of California, San Francisco) for the CD47-Fc plasmid; J. Yuan and C.J. Guidos (Hospital for Sick Children) for human IgG-Fc control protein; the Kirin Brewery for MS-5 cells; M. Huang (GenPharm) for Rag and derivative mice; and N. Crispe for experimental advice. Supported by the Juvenile Diabetes Research Foundation (J.S.D.), Genome Canada with funding through the Ontario Genomics Institute (J.S.D. and J.E.D.), the Leukemia and Lymphoma Society Specialized Center of Research (J.S.D. and J.E.D.), the Ontario Ministry of Research and Innovation (J.S.D.), the Canadian Institute of Health Research (J.E.D.), a Canada Research Chair (J.E.D.), the Ontario Institute for Cancer Research with funds from the Province of Ontario (J.E.D.), and National Cancer Institute of Canada with funds from the Canadian Cancer Society and Terry Fox Foundation (J.E.D.).
Author information
Authors and Affiliations
Contributions
K.T. and T.K.P. designed and did experiments, analyzed data and wrote the manuscript; J.C.Y.W. did experiments, analyzed data and wrote the manuscript; S.M.M-T. did experiments and reviewed the manuscript; S.K. did sequencing experiments and bioinformatics analysis; O.I.G. did experiments, analyzed data and reviewed the manuscript; and J.E.D. and J.S.D. designed experiments, analyzed data and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
A provisional patent related to this study has been filed.
Supplementary information
Supplementary Text and Figures
Supplementary Tables 1–5 (PDF 225 kb)
Rights and permissions
About this article
Cite this article
Takenaka, K., Prasolava, T., Wang, J. et al. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol 8, 1313–1323 (2007). https://doi.org/10.1038/ni1527
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni1527
This article is cited by
-
Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma
Nature Communications (2024)
-
Humanized mouse models for immuno-oncology research
Nature Reviews Clinical Oncology (2023)
-
Characterization of human Fc alpha receptor transgenic mice: comparison of CD89 expression and antibody-dependent tumor killing between mouse strains
Cancer Immunology, Immunotherapy (2023)
-
Blockade of CD47 enhances the antitumor effect of macrophages in renal cell carcinoma through trogocytosis
Scientific Reports (2022)
-
miR-1224 contributes to ischemic stroke-mediated natural killer cell dysfunction by targeting Sp1 signaling
Journal of Neuroinflammation (2021)